365 related articles for article (PubMed ID: 27616483)
1. GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers.
Li D; Yuan H; Ortiz-Gonzalez XR; Marsh ED; Tian L; McCormick EM; Kosobucki GJ; Chen W; Schulien AJ; Chiavacci R; Tankovic A; Naase C; Brueckner F; von Stülpnagel-Steinbeis C; Hu C; Kusumoto H; Hedrich UB; Elsen G; Hörtnagel K; Aizenman E; Lemke JR; Hakonarson H; Traynelis SF; Falk MJ
Am J Hum Genet; 2016 Oct; 99(4):802-816. PubMed ID: 27616483
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous clinical and functional features of GRIN2D-related developmental and epileptic encephalopathy.
XiangWei W; Kannan V; Xu Y; Kosobucki GJ; Schulien AJ; Kusumoto H; Moufawad El Achkar C; Bhattacharya S; Lesca G; Nguyen S; Helbig KL; Cuisset JM; Fenger CD; Marjanovic D; Schuler E; Wu Y; Bao X; Zhang Y; Dirkx N; Schoonjans AS; Syrbe S; Myers SJ; Poduri A; Aizenman E; Traynelis SF; Lemke JR; Yuan H; Jiang Y
Brain; 2019 Oct; 142(10):3009-3027. PubMed ID: 31504254
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of a de novo GRIN2A missense mutation associated with early-onset epileptic encephalopathy.
Yuan H; Hansen KB; Zhang J; Pierson TM; Markello TC; Fajardo KV; Holloman CM; Golas G; Adams DR; Boerkoel CF; Gahl WA; Traynelis SF
Nat Commun; 2014; 5():3251. PubMed ID: 24504326
[TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.
Ogden KK; Chen W; Swanger SA; McDaniel MJ; Fan LZ; Hu C; Tankovic A; Kusumoto H; Kosobucki GJ; Schulien AJ; Su Z; Pecha J; Bhattacharya S; Petrovski S; Cohen AE; Aizenman E; Traynelis SF; Yuan H
PLoS Genet; 2017 Jan; 13(1):e1006536. PubMed ID: 28095420
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel GRIN2D variant in a neonate with intractable epileptic encephalopathy-a case report.
Jiao J; Li L; Sun M; Fang J; Meng L; Zhang Y; Jia C; Ma L
BMC Pediatr; 2021 Jan; 21(1):5. PubMed ID: 33397303
[TBL] [Abstract][Full Text] [Related]
6. Perampanel therapy for intractable GRIN2D-related developmental and epileptic encephalopathy: A case report and literature review.
Li J; Zhou Y; Su T; Xu S
Brain Dev; 2023 Apr; 45(4):237-243. PubMed ID: 36567197
[TBL] [Abstract][Full Text] [Related]
7. GRIN2D/GluN2D NMDA receptor: Unique features and its contribution to pediatric developmental and epileptic encephalopathy.
Camp CR; Yuan H
Eur J Paediatr Neurol; 2020 Jan; 24():89-99. PubMed ID: 31918992
[TBL] [Abstract][Full Text] [Related]
8. GRIN2D variants in three cases of developmental and epileptic encephalopathy.
Tsuchida N; Hamada K; Shiina M; Kato M; Kobayashi Y; Tohyama J; Kimura K; Hoshino K; Ganesan V; Teik KW; Nakashima M; Mitsuhashi S; Mizuguchi T; Takata A; Miyake N; Saitsu H; Ogata K; Miyatake S; Matsumoto N
Clin Genet; 2018 Dec; 94(6):538-547. PubMed ID: 30280376
[TBL] [Abstract][Full Text] [Related]
9. Recurrent seizure-related GRIN1 variant: Molecular mechanism and targeted therapy.
Xu Y; Song R; Chen W; Strong K; Shrey D; Gedela S; Traynelis SF; Zhang G; Yuan H
Ann Clin Transl Neurol; 2021 Jul; 8(7):1480-1494. PubMed ID: 34227748
[TBL] [Abstract][Full Text] [Related]
10. Functional Evaluation of a De Novo
Chen W; Tankovic A; Burger PB; Kusumoto H; Traynelis SF; Yuan H
Mol Pharmacol; 2017 Apr; 91(4):317-330. PubMed ID: 28126851
[TBL] [Abstract][Full Text] [Related]
11. A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia.
Gao K; Tankovic A; Zhang Y; Kusumoto H; Zhang J; Chen W; XiangWei W; Shaulsky GH; Hu C; Traynelis SF; Yuan H; Jiang Y
PLoS One; 2017; 12(2):e0170818. PubMed ID: 28182669
[TBL] [Abstract][Full Text] [Related]
12. Favorable Response to "Memantine" in a Child with GRIN2B Epileptic Encephalopathy.
Chidambaram S; Manokaran RK
Neuropediatrics; 2022 Aug; 53(4):287-290. PubMed ID: 34844267
[No Abstract] [Full Text] [Related]
13. Neonatal SCN2A encephalopathy: A peculiar recognizable electroclinical sequence.
Melikishvili G; Dulac O; Gataullina S
Epilepsy Behav; 2020 Oct; 111():107187. PubMed ID: 32603808
[TBL] [Abstract][Full Text] [Related]
14. Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization.
Glasgow NG; Povysheva NV; Azofeifa AM; Johnson JW
J Neurosci; 2017 Oct; 37(40):9686-9704. PubMed ID: 28877967
[TBL] [Abstract][Full Text] [Related]
15. Altered zinc sensitivity of NMDA receptors harboring clinically-relevant mutations.
Serraz B; Grand T; Paoletti P
Neuropharmacology; 2016 Oct; 109():196-204. PubMed ID: 27288002
[TBL] [Abstract][Full Text] [Related]
16. Reprogramming of two induced pluripotent stem cell lines from a heterozygous GRIN2D developmental and epileptic encephalopathy (DEE) patient (BGUi011-A) and from a healthy family relative (BGUi012-A).
Rabinski T; Sagiv ST; Hausman-Kedem M; Fattal-Valevski A; Rubinstein M; Avraham KB; Vatine GD
Stem Cell Res; 2021 Mar; 51():102178. PubMed ID: 33482465
[TBL] [Abstract][Full Text] [Related]
17. GRIN2B gain of function mutations are sensitive to radiprodil, a negative allosteric modulator of GluN2B-containing NMDA receptors.
Mullier B; Wolff C; Sands ZA; Ghisdal P; Muglia P; Kaminski RM; André VM
Neuropharmacology; 2017 Sep; 123():322-331. PubMed ID: 28533163
[TBL] [Abstract][Full Text] [Related]
18. Site within N-Methyl-D-aspartate receptor pore modulates channel gating.
Chen N; Li B; Murphy TH; Raymond LA
Mol Pharmacol; 2004 Jan; 65(1):157-64. PubMed ID: 14722247
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains.
Swanger SA; Chen W; Wells G; Burger PB; Tankovic A; Bhattacharya S; Strong KL; Hu C; Kusumoto H; Zhang J; Adams DR; Millichap JJ; Petrovski S; Traynelis SF; Yuan H
Am J Hum Genet; 2016 Dec; 99(6):1261-1280. PubMed ID: 27839871
[TBL] [Abstract][Full Text] [Related]
20. Modelling and treating GRIN2A developmental and epileptic encephalopathy in mice.
Amador A; Bostick CD; Olson H; Peters J; Camp CR; Krizay D; Chen W; Han W; Tang W; Kanber A; Kim S; Teoh J; Sah M; Petri S; Paek H; Kim A; Lutz CM; Yang M; Myers SJ; Bhattacharya S; Yuan H; Goldstein DB; Poduri A; Boland MJ; Traynelis SF; Frankel WN
Brain; 2020 Jul; 143(7):2039-2057. PubMed ID: 32577763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
